Education
About Us
Working with TipRanks
Follow Us
Innovation1 Biotech (IVBT)
:IVBT
Total Valuation
Innovation1 Biotech has a market cap or net worth of $4.49K. The enterprise value is ―.
Market Cap$4.49K
Enterprise Value―
Share Statistics
Innovation1 Biotech has 22,470,240 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding22,470,240
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Innovation1 Biotech’s return on equity (ROE) is 1.75 and return on invested capital (ROIC) is 42.72%.
Return on Equity (ROE)1.75
Return on Assets (ROA)-78.80
Return on Invested Capital (ROIC)42.72%
Return on Capital Employed (ROCE)0.43
Revenue Per Employee0.00
Profits Per Employee-5.99M
Employee Count1
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Innovation1 Biotech is -2.87. Innovation1 Biotech’s PEG ratio is 0.04.
PE Ratio-2.87
PS Ratio―
PB Ratio-5.00
Price to Fair Value-5.00
Price to FCF-27.66
Price to Operating Cash Flow-27.66
PEG Ratio0.04
Income Statement
In the last 12 months, Innovation1 Biotech had revenue of 0.00 and earned -5.99M in profits. Earnings per share was -0.70.
Revenue0.00
Gross Profit-52.70K
Operating Income-1.37M
Pretax Income-5.99M
Net Income-5.99M
EBITDA-5.68M
Earnings Per Share (EPS)-0.70
Cash Flow
In the last 12 months, operating cash flow was -575.88K and capital expenditures 0.00, giving a free cash flow of -575.88K billion.
Operating Cash Flow-575.88K
Free Cash Flow-575.88K
Free Cash Flow per Share-0.03
Dividends & Yields
Innovation1 Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.09
52-Week Price Change0.00%
50-Day Moving Average0.02
200-Day Moving Average0.02
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
Innovation1 Biotech upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Innovation1 Biotech as a current ratio of 0.02, with Debt / Equity ratio of -6.68%
Current Ratio0.02
Quick Ratio0.02
Debt to Market Cap0.01
Net Debt to EBITDA-0.03
Interest Coverage Ratio-5.43
Taxes
In the past 12 months, Innovation1 Biotech has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Innovation1 Biotech EV to EBITDA ratio is -3.05, with an EV/FCF ratio of -27.95.
EV to Sales0.00
EV to EBITDA-3.05
EV to Free Cash Flow-27.95
EV to Operating Cash Flow-27.95
Balance Sheet
Innovation1 Biotech has $5.82K in cash and marketable securities with $0.00 in debt, giving a net cash position of $458.73K billion.
Cash & Marketable Securities$5.82K
Total Debt$0.00
Net Cash$458.73K
Net Cash Per Share$0.02
Tangible Book Value Per Share-$0.17
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Innovation1 Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―